Your browser doesn't support javascript.
loading
Targeting T Cell Metabolism as a Novel Approach for Treatment of MS: With a Focus on PFKFB3 Inhibitors.
Vakili, Mahsa Eshkevar; Shah Mohammadi, Fateme Nezhad; Ataollahi, Mohammad Reza; Shams, Keivan; Eklund, Kari K; Daryabor, Gholamreza; Kalantar, Kurosh.
Afiliación
  • Vakili ME; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shah Mohammadi FN; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Ataollahi MR; Department of Immunology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
  • Shams K; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Eklund KK; Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Helsinki, Finland.
  • Daryabor G; Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Kalantar K; Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Article en En | MEDLINE | ID: mdl-36154602

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Emiratos Árabes Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Asunto de la revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Emiratos Árabes Unidos